MyFinsight
Home
Blog
About
Cash and cash
equivalents
$5,338K
(48.07%↑ Y/Y)
Prepaid expenses and
other current assets
$3,962K
(38.15%↑ Y/Y)
Inventories, net
$3,786K
(-0.42%↓ Y/Y)
Accounts receivable, net
$3,182K
(22.29%↑ Y/Y)
Total current assets
$16,268K
(24.12%↑ Y/Y)
Deferred tax asset, net
$905K
(65.75%↑ Y/Y)
Operating lease, right of
use assets
$578K
(7.84%↑ Y/Y)
Property and equipment,
net
$290K
(-3.65%↓ Y/Y)
Other assets
$66K
(-17.50%↓ Y/Y)
Total assets
$18,107K
(24.07%↑ Y/Y)
Total liabilities and
stockholders equity
$18,107K
(24.07%↑ Y/Y)
Total liabilities
$11,513K
(9.25%↑ Y/Y)
Total stockholders
equity
$6,594K
(62.57%↑ Y/Y)
Accumulated deficit
-$201,311K
(-1.14%↓ Y/Y)
Accumulated other
comprehensive loss
-$3,008K
(15.74%↑ Y/Y)
Withholding tax payable
$5,627K
(7.26%↑ Y/Y)
Total current
liabilities
$5,447K
(12.36%↑ Y/Y)
Operating lease
liabilities, less current...
$439K
(-0.23%↓ Y/Y)
Additional paid-in capital
$210,913K
(2.05%↑ Y/Y)
Accrued expenses and
other current...
$2,674K
(45.64%↑ Y/Y)
Accounts payable
$2,191K
(7.09%↑ Y/Y)
Deferred revenue
$282K
(-61.42%↓ Y/Y)
Operating lease
liabilities, current portion
$160K
(66.67%↑ Y/Y)
Short-term debt
$140K
(0.72%↑ Y/Y)
Back
Back
Balance Sheet
Sonoma Pharmaceuticals, Inc. (SNOA)
Sonoma Pharmaceuticals, Inc. (SNOA)
source: myfinsight.com